Show simple item record

dc.contributor.authorNakku-Joloba, Edith
dc.contributor.authorKambugu, Fred
dc.contributor.authorWasubire, Julias
dc.contributor.authorKimeze, Joshua
dc.contributor.authorSalata, Robert
dc.contributor.authorAlbert, Jeffrey M.
dc.contributor.authorRimm, Alfred
dc.contributor.authorWhalen, Christopher
dc.date.accessioned2015-02-03T12:05:24Z
dc.date.available2015-02-03T12:05:24Z
dc.date.issued2014
dc.identifier.citationNakku-Joloba, E et al (2014). Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda. African Health Sciences 14(4): 782-789.en_US
dc.identifier.otherDOI: http://dx.doi.org/10.4314/ahs.v14i4.2
dc.identifier.urihttp://hdl.handle.net/10570/4306
dc.descriptionPublished journal articleen_US
dc.description.abstractBackground: Prevalence of herpes simplex type 2 virus (HSV-2) is high worldwide. Previous studies in Uganda were rural or in women. We estimated age and sex-specific sero- prevalence of HSV-2 in Kampala, Uganda. Methods: Using two-stage random sampling stratified on population density, a survey of persons 15-65 years was conducted. Type-specific serological tests for HSV-2, HSV-1(HerpeSelect2 and 1 ELISA), HIV (Rapid tests and ELISA), syphilis (RPR and TPHA) were done. Additional prevalence analysis included post-stratification weighting on the Uganda 2002 Census gender distribution. Results: Among 1124 persons, HSV-2 prevalence was 58% (95% CI: 55, 60), HSV-1; 98% (95% CI: 97.6, 99.1), HIV; 17.7% (95% CI: 14.8, 19.2) and syphilis; 1.7% (95% CI: 1.4, 1.9). Weighted HSV-2 prevalence was 53.8% (Women; 63.8%, men; 43.2%), similar to unweighted data. Weighted HIV prevalence was 20.7% in women, 8.6% in men. Of 165 HIV infected persons, 85.4% had HSV-2. Risk factors for HSV-2 were being a woman (OR 2.0; 95% CI: 1.42, 2.78), age (OR 3.3; 95% CI: 2.43, 4.53), education (OR 1.70; 95% CI: 1.34, 2.34) and HIV (OR 4.5; 95% CI: 2.70, 7.50). Conclusion: Prevalence of HSV-2 and HIV was high especially in women. Syphilis was rare. Awareness of herpes was low. Interventions in young people are needed.en_US
dc.description.sponsorshipThis work was supported by the National Institutes of Health, Fogarty International Center and the National Institutes of Health Office of Women’s Health of the United States under the Global Research Initiative Program for New Foreign Investigators (GRIP) Grant Number TW006672-01 and the Government of Uganda, Ministry of Health.en_US
dc.language.isoenen_US
dc.publisherAfrican Health Sciencesen_US
dc.subjectHSV-2en_US
dc.subjectHIVen_US
dc.subjectKampalaen_US
dc.subjectUgandaen_US
dc.titleSero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Ugandaen_US
dc.typeJournal articleen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record